ity of appropriate acquisition candidates and Lincare's ability to
successfully complete and integrate acquisitions, efficient operation of
Lincare's existing and future operating facilities, regulation and/or
regulatory action affecting Lincare or its business, economic and
competitive conditions, access to borrowed and/or equity capital on
favorable terms and other risks described in the filings of Lincare with
the Securities and Exchange Commission.
In developing its forward-looking statements, Lincare has made certain
assumptions relating to reimbursement rates and policies, internal growth
and acquisitions and the outcome of various legal and regulatory
proceedings. If the assumptions used by Lincare differ materially from what
actually occurs, then actual results could vary significantly from the
performance projected in the forward-looking statements. Lincare is under
no duty to update any of the forward-looking statements after the date of
this release.
LINCARE HOLDINGS INC.
Financial Summary
(Unaudited)
(In thousands, except share and per share data)
For the three months ended
March 31, March 31,
2008 2007
Net revenues $415,420 $378,459
Costs and expenses:
Costs of goods and services 97,587 88,134
Operating expenses 96,278 91,884
Selling, general and administrative
expenses 82,195 76,367
Bad debt expense 6,231 5,677
Depreciation expense 29,509 25,901
Amo
'/>"/>
SOURCE Lincare Holdings Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results2.
Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering3.
Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement4.
Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results5.
Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders6.
China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.7.
China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line8.
AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange9.
Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved10.
Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 200711.
Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.